Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 061613/0897 | |
| Pages: | 77 |
| | Recorded: | 09/27/2022 | | |
| Attorney Dkt #: | MDAC.P1264US/D1/D1C1/D1C2 |
| Conveyance: | MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
4
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/07/2017
|
Application #:
|
12677035
|
Filing Dt:
|
04/08/2010
|
|
Publication #:
|
|
Pub Dt:
|
12/30/2010
| | | | |
|
Title:
|
ENHANCED GENERATION OF CYTOTOXIC T-LYMPHOCYTES BY IL-21 MEDIATED FOXP3 SUPPRESSION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/11/2018
|
Application #:
|
15188096
|
Filing Dt:
|
06/21/2016
|
|
Publication #:
|
|
Pub Dt:
|
10/13/2016
| | | | |
|
Title:
|
ENHANCED GENERATION OF CYTOTOXIC T LYMPHOCYTES BY IL-21 MEDIATED FOXP3 SUPPRESSION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/24/2021
|
Application #:
|
16100113
|
Filing Dt:
|
08/09/2018
|
|
Publication #:
|
|
Pub Dt:
|
01/24/2019
| | | | |
|
Title:
|
ENHANCED GENERATION OF CYTOTOXIC T-LYMPHOCYTES BY IL-21 MEDIATED FOXP3 SUPPRESSION
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17400038
|
Filing Dt:
|
08/11/2021
|
|
Publication #:
|
|
Pub Dt:
|
03/10/2022
| | | | |
|
Title:
|
ENHANCED GENERATION OF CYTOTOXIC T-LYMPHOCYTES BY IL-21 MEDIATED FOXP3 SUPPRESSION
|
|
|
Assignor
|
|
|
|
|
|
Newly Merged Entity Data
|
|
|
|
|
|
Newly Merged Entity's New Name
|
|
|
|
|
| 1100 FAIRVIEW AVENUE N |
| SEATTLE, WASHINGTON 98109 |
|
|
Correspondence name and address
|
| |
NORTON ROSE FULBRIGHT US LLP
|
| |
98 SAN JACINTO BLVD., SUITE 1100
|
| |
AUSTIN, TX 78701
|
Search Results as of:
05/24/2024 06:48 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
